Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cilostazol Stroke Prevention Study for Antiplatelet Combination

NCT01995370 is registered in ClinicalTrials.gov with Japan Cardiovascular Research Foundation as lead sponsor.

NCT NCT01995370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01995370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cilostazol Stroke Prevention Study for Antiplatelet Combination
Lead sponsor
Japan Cardiovascular Research Foundation
Phase
Phase 4
Overall status
Completed
Start date
December 13, 2013
Completion date
December 7, 2018
Enrollment
1,884 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

noncardioembolic cerebral infarction